6-Thioguanine
SIGMA/A4660 - Hybri-Max™, 50 ×, γ-irradiated, lyophilized powder, BioXtra, suitable for hybridoma
Synonym: 2-
CAS Number: 154-42-7
Empirical Formula (Hill Notation): C5H5N5S
Molecular Weight: 167.19
EC Number: 205-827-2
MDL Number: MFCD00233553
Linear Formula: C5H5N5S
Product Type: Chemical
assay | ~98% |
biological source | synthetic (organic) |
concentration | 50 × |
form | lyophilized powder |
grade | Hybri-Max™ |
impurities | endotoxin, tested |
InChI | 1S/C5H5N5S/c6-5-9-3-2(4(1 |
InChI key | WYWHKKSPHMUBEB-UHFFFAOYSA |
mp | ≥300 °C (lit.) |
product line | BioXtra |
Quality Level | 200 |
SMILES string | NC1=Nc2nc[nH]c2C(=S)N1 |
solubility | 1 M NaOH: 50 mg/mL, clear to slightly hazy |
sterility | γ-irradiated |
storage temp. | room temp |
technique(s) | cell culture | hybridoma: suitable |
Application: | Used in hybridoma formation applications as a selection agent. |
Biochem/physiol Actions: | Ribosylated and phosphorylated by the same pathway as natural purine bases; as the nucleotide, inhibits a variety of cellular processes involved in nucleic acid synthesis. Has a long history as an effective treatment of leukemia. |
Legal Information: | Hybri-Max is a trademark of Sigma-Aldrich Co. LLC |
Reconstitution: | Reconstitute contents of vial with 10 ml sterile cell culture medium. Stock solution is sufficient to prepare 500 ml medium. Final working concentration: 30 μM 2-amino-6-mercaptopurine. |
Symbol | GHS06 |
Signal word | Danger |
Hazard statements | H301 |
Precautionary statements | P301 + P310 |
Hazard Codes | T |
Risk Statements | 25 |
Safety Statements | 28-36/37/39-45 |
RIDADR | UN 2811 6.1 / PGIII |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Purity | ~98% |
mp | ≥300 °C (lit.) |
Storage Temp. | room temp |
UNSPSC | 12352207 |